Anthera Pharmaceuticals, Inc. (ANTH)

[Paulieme]

California State Teachers Retirement System Increases Stake in Anthera Pharmaceuticals Inc (ANTH)
February 6th, 2016 • California State Teachers Retirement System raised its stake in Anthera Pharmaceuticals Inc (NASDAQ:ANTH) by 1.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 73,476 shares of the biopharmaceutical company’s stock after buying an additional 1,263 shares during the period. California State Teachers Retirement System owned 0.18% of Anthera Pharmaceuticals worth $341,000 at the end of the most recent reporting period.

Shares of Anthera Pharmaceuticals Inc (NASDAQ:ANTH) opened at 2.67 on Friday. Anthera Pharmaceuticals Inc has a 12 month low of $2.51 and a 12 month high of $11.65. The firm’s market capitalization is $106.47 million. The firm’s 50 day moving average is $3.72 and its 200-day moving average is $6.33.

Separately, Zacks Investment Research downgraded shares of Anthera Pharmaceuticals from a “buy” rating to a “hold” rating in a research note on Monday, January 18th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $11.85.



In other news, insider Colin Hislop sold 12,500 shares of the company’s stock in a transaction on Friday, November 13th. The shares were sold at an average price of $5.31, for a total transaction of $66,375.00. Following the transaction, the insider now directly owns 19,147 shares of the company’s stock, valued at approximately $101,670.57. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Anthera Pharmaceuticals Inc (NASDAQ:ANTH) is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation and autoimmune diseases. The Company’s primary Phase 3 product candidate blisibimod targets elevated levels of Bcell activating factor (BAFF) which has been associated with a variety of Bcell mediated autoimmune diseases including systemic lupus erythematosus or lupus IgA nephropathy lupus nephritis multiple myeloma and others.

12 Month Chart for NASDAQ:ANTH


Receive News & Ratings for Anthera Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthera Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter. http://www.americanbankingnews.com/2016/02/06/california-state-teachers-retirement-system-increases-stake-in-anthera-pharmaceuticals-inc-anth/